Duodote Kit
Product Images NDC 11704-620

Product Visual Gallery

This gallery contains 14 technical images submitted to the FDA as part of the official labeling for Duodote (NDC 11704-620). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Meridian Medical Technologies� Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Duo04 0012 01

Chemical structures of atropine and pralidoxime chloride. The image shows the molecular structures for both active ingredients found in DuoDote, displaying their respective chemical bonds and functional groups.*

FDA Label Image

Duo04 0012 02

Line graph showing atropine plasma levels (mg/L) over time (minutes) ranging from 0 to 720 minutes. The graph depicts a decrease in plasma levels as time progresses, starting at a higher concentration and gradually declining towards zero.*

FDA Label Image

Duo04 0012 03

A line graph depicting pralidoxime plasma levels (mcg/mL) on the vertical axis over time in minutes on the horizontal axis. The plot shows a decline in plasma concentration over a period of up to 720 minutes.*

FDA Label Image

Duo04 0012 04

The image shows a DuoDote kit package label, containing atropine and pralidoxime chloride for intramuscular injection. The label states use for nerve agent or insecticide poisoning, with dosing recommendations for adults and pediatric patients weighing 90 lb or more. The labeler is Meridian Medical Technologies LLC.*

FDA Label Image

Duo04 0012 05

An instructional illustration showing hands holding a DuoDote kit. The two-panel image demonstrates how to prepare the DuoDote kit for intramuscular injection, including removing or adjusting parts of the kit. The labeling and packaging details are not visible in this illustration.*

FDA Label Image

Duo04 0012 06

An instructional diagram showing a hand holding a DuoDote kit for intramuscular injection. The diagram highlights the gray safety release and the green tip of the device.*

FDA Label Image

Duo04 0012 07

An instructional illustration showing hands removing a gray safety release cap from a DuoDote intramuscular injection kit. The image demonstrates proper handling and preparation of the DuoDote kit containing atropine and pralidoxime chloride by Meridian Medical Technologies LLC.*

FDA Label Image

Duo04 0012 08

An instructional illustration showing two panels: self-administration technique for healthcare providers involving arm injection, and administration to a patient lying down, demonstrating intramuscular injection procedures for a medical kit.*

FDA Label Image

Duo04 0012 09

Illustrations showing the self-administration of DuoDote kit for healthcare providers and its administration to a patient. The diagrams depict the proper method to use the intramuscular injection. The images serve as instructional guidance for this human prescription drug kit by Meridian Medical Technologies LLC.*

FDA Label Image

Duo04 0012 10

An instructional illustration depicting two hands holding an intramuscular injection device for DuoDote, a kit containing atropine and pralidoxime chloride. One image shows the needle visible before injection, and the other shows the needle not visible after injection.*

FDA Label Image

Duo04 0012 11

An instructional illustration showing a hand holding and preparing to use a DuoDote intramuscular injection kit containing atropine and pralidoxime chloride. The image demonstrates the correct positioning and angle for administration.*

FDA Label Image

Duo04 0012 12

DuoDote single-dose auto-injector kit containing atropine and pralidoxime chloride for intramuscular injection. The packaging shows dosing information for adults and pediatric patients weighing 41 kg or more, with instructions for safe use including needle safety features. The labeler is Meridian Medical Technologies LLC.*

FDA Label Image

Duo04 0012 13

DuoDote single-dose auto-injector kit label showing atropine and pralidoxime chloride injection for intramuscular use. The label indicates it is for nerve agent or insecticide poisoning in adults and pediatric patients weighing 41 kg (90 lb) or more. Manufactured by Meridian Medical Technologies, the label includes dosage details and storage instructions.*

FDA Label Image

Duo04 0012 14

The DuoDote single-dose auto-injector label shows instructions with illustrations for intramuscular injection by Meridian Medical Technologies LLC. The label highlights atropine and pralidoxime chloride injection for nerve agent or insecticide poisoning, for patients weighing 41 kg or 90 lb and above. It advises pulling off the gray safety release, firmly pushing the green tip against the outer thigh until a click, holding for about 10 seconds, and seeking medical attention.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.